Work

Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Year: 2025

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-25-1402

Authors: Kimberly A. Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni, Rafal Pacholczyk, Karina Vázquez-Arreguín, Shilpa Sharma, Kimya Jones, Kailash Vemuri, Upasana Sahu, Sara A. Murphy, Bangxing Hong, Ravindra Kolhe, Ashok Sharma, Balveen Kaur

Institutions: The University of Texas MD Anderson Cancer Center, Augusta University, The University of Texas Health Science Center at Houston

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: Next Gen Virotherapy for GBM, Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma, Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas, Development of murine glioblastoma model for oncolytic HSV therapy

OpenAlex ID: W4417475420

FWCI: 0.533

Cites: 55

Cited by: 1

Related to: